首页> 外国专利> 9-35--5889-3'4':67-23-13-65- NEW 9-35-DIMETHOXYPHENYL-588a9-TETRAHYDROFURO3'4':67NAPHTHO-23-d13DIOXOL-65aH-ONE COMPOUNDS A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

9-35--5889-3'4':67-23-13-65- NEW 9-35-DIMETHOXYPHENYL-588a9-TETRAHYDROFURO3'4':67NAPHTHO-23-d13DIOXOL-65aH-ONE COMPOUNDS A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

机译:9-35--5889- [3'4':67]-[23-] [13] -65-新的9-35-二甲氧基苯基-588a9-四氢呋喃[3'4':67] NAPHTHO- [23-d ] [13] DIOXOL-65aH-one化合物一种制备其的方法和包含它们的药物组合物

摘要

PURPOSE: Provided are 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro-(3',4':6,7)naphtho(2,3-d)(1,3)dioxol-6(5aH)-one compounds which are natural products useful for the treatment of cancer, their preparation method, and a pharmaceutical composition containing them. CONSTITUTION: 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro-(3',4':6,7)naphtho(2,3-d)(1,3)dioxol-6(5aH)-one compound is represented by the formula(I), wherein wherein:R represents:a group of formula(I): wherein X, Y and W are as defined in the description,or a group of formula(II) of -A-G: wherein:A represents a single bond or an optionally substituted alkylene chain,G represents a group selected from hydrogen, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, -OR2, -O-T1-NR3R4, -O-T1-NR2-T'1-NR3R4, -NR3R4, -NR2-T1-NR3R4, -NR2-T1-OR5, -NR2-T1-CO2R6, -NR2-T1-C(O)R6, -C(O)-NR3R4, -C(O)-NR2-T2, -O-C(O)T2, -O-C(S)-T2, -NR2-C(O)-T2, -NR2-C(S)-T2, -O-C(O)-O-T2, -O-C(O)-NR2-T2, -O-C(S)-O-T2, -O-C(S)-NR2-T2, -NR2-C(O)-O-T2, -NR2-C(O)-NR-T2, -NR2-C(S)-O-T2, -NR2-C(S)-NR6-T2 and -NR2-SO2-T3, wherein R2, R3, R4, R5, R6, T1, T'1, T2 and T3 are as defined in the description,R1 represents a group selected from hydrogen, alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, alkylcarbonyl, arylcarbonyl, arylalkylcarbonyl, heterocycloalkylcarbonyl, alkylsulphonyl, arylsulphonyl, arylalkylsulphonyl, phosphono, aryloxycarbonyl, alkoxycarbonyl and arylalkoxycarbonyl,its isomers, and also addition salts thereof with a pharmaceutically acceptable acid or base.Medicinal products containing the same which are useful in the treatment of cancer.
机译:用途:提供9-(3,5-二甲氧基苯基)-5,8,8a,9-四氢呋喃-(3',4':6,7)萘(2,3-d)(1,3)二氧杂酚-作为用于治疗癌症的天然产物的6(5aH)-一化合物,其制备方法和含有它们的药物组合物。组成:9-(3,5-二甲氧基苯基)-5,8,8a,9-四氢呋喃-(3',4':6,7)萘(2,3-d)(1,3)dioxol-6( 5aH)-化合物由式(I)表示,其中:R代表:式(I)的基团:其中X,Y和W如说明书中所定义,或式(II)的基团-AG:其中:A代表单键或任选取代的亚烷基链,G代表选自氢,环烷基,杂环烷基,芳基,杂芳基,-OR2,-O-T1-NR3R4,-O-T1-NR2-的基团。 T'1-NR3R4,-NR3R4,-NR2-T1-NR3R4,-NR2-T1-OR5,-NR2-T1-CO2R6,-NR2-T1-C(O)R6,-C(O)-NR3R4,- C(O)-NR2-T2,-OC(O)T2,-OC(S)-T2,-NR2-C(O)-T2,-NR2-C(S)-T2,-OC(O)- O-T2,-OC(O)-NR2-T2,-OC(S)-O-T2,-OC(S)-NR2-T2,-NR2-C(O)-O-T2,-NR2-C (O)-NR-T2,-NR2-C(S)-O-T2,-NR2-C(S)-NR6-T2和-NR2-SO2-T3,其中R2,R3,R4,R5,R6, T1,T'1,T2和T3如说明书中所定义,R1代表选自氢,烷基,芳基,芳基烷基,杂芳基,杂芳基烷基,烷基羰基,芳基羰基的基团。 ,芳基烷基羰基,杂环烷基羰基,烷基磺酰基,芳基磺酰基,芳基烷基磺酰基,膦酰基,芳氧基羰基,烷氧基羰基和芳基烷氧基羰基,其异构体,以及它们与可药用酸或碱的加成盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号